Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.
Clinical trial NCT05667740 · COMPLETED
Trial details
- NCT number
- NCT05667740
- Sponsor
- GPN Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-16
- Primary completion
- 2023-10-08
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.